ProteoCell Biotechnologies inc. is a bioprocess specialty company that focuses on recombinant protein development and production using the latest in-vitro cell culture and purification technologies. We start at the pre-clinical stage, expressing the clone, through bioprocess scale-up, and continue into the larger scale production of recombinant products. Be it cell line engineering or bioprocess engineering, we work through all facets of the production development, manufacturing, and associated auxiliary services to provide you with the right bioprocess solutions.
Whether it's a pre-clinical therapeutic or clinical grade diagnostic molecule, a chimeric Antibody or a vaccine, ProteoCell's team works with you to make sure that your bioprocess is optimized from the early stages to the end. We also provide a list of other associated auxiliary services including pre-clinical toxicity testing and validation, to a limited amount of facility and equipment validation.